Chiara Minotti

Dr. Chiara Minotti

University of Padua, Padua, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Infection
Verified
Journal Article
Closed access
CMChiara Minotti
Chiara Minotti
FTFrancesca Tirelli
Francesca Tirelli
EBElisa Barbieri
Elisa Barbieri
CGCarlo Giaquinto
Carlo Giaquinto
DDDaniele Donà
Daniele Donà

1 September 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
PCPaola Costenaro
Paola Costenaro
CMChiara Minotti
Chiara Minotti
EBElisa Barbieri
Elisa Barbieri
CGCarlo Giaquinto
Carlo Giaquinto
DDDaniele Donà
Daniele Donà

16 April 2020 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
DDDaniele Donà
Daniele Donà
CMChiara Minotti
Chiara Minotti
PCPaola Costenaro
Paola Costenaro
LDLiviana Da Dalt
Liviana Da Dalt
CGCarlo Giaquinto
Carlo Giaquinto
Starting from 2 pediatric cases of COVID-19, with confirmation at nasopharyngeal and rectal swabs, we considered the lesson learnt from previous Coronavirus epidemics and reviewed evidence on the current outbreak. Surveillance with rectal swabs might be extended to infants and children, for the implications for household contacts and isolation timing.

2 February 2024 in eClinicalMedicine
Verified
Journal Article
Open access
CMChiara Minotti
Chiara Minotti
CMCarla McKenzie
Carla McKenzie
IDIsabelle Dewandel
Isabelle Dewandel
CBCarien Bekker
Carien Bekker
GSGiulia Sturniolo
Giulia Sturniolo
DDDaniele Donà
Daniele Donà
Post Coronavirus disease (COVID) and other post-viral infection syndromes present an overlap of pathogenesis, onset, progression, and symptom profile. We aimed to systematically describe studies on post-viral conditions and determine the entity of post COVID compared to other post-viral conditions in children. We conducted a systematic search of the Embase, MEDLINE, Cochrane Library, and GoogleScholar databases (January 1946–3 November 2023), according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The main outcomes were differences in condition duration, symptom type, and development of chronic symptoms. This systematic review was registered on PROSPERO (CRD42023401789). 35/5051 studies were included, with 42,934 children, adolescents and young adults (0–20 years old) overall. Twenty-eight studies focused on post COVID symptoms, followed by five papers on Respiratory Syncytial Virus (RSV) and Rhinovirus, one study on Epstein–Barr Virus (EBV), and one on gastrointestinal viruses. Studies on post COVID mainly reported data on older children/adolescents, describing long-lasting symptoms, including fatigue, neurologic, cardiorespiratory, musculoskeletal, mental health, and gastrointestinal symptoms. The maximum described symptoms duration was eighteen months, with an average follow-up of seven months. The development of chronic symptoms was reported by 30 studies (93.8%) for 10,473/28,474 patients (36.8%). Recovery was achieved in 18,001/28,474 cases (63.2%). The study on EBV reported persistent fatigue in adolescents for a similar duration (6 months, 46% chronic). Studies on RSV and Rhinovirus were mainly done in children under three years, with development of recurrent wheezing (up to 3 years). Post-viral fatigue was a shared feature between post COVID and post EBV conditions. A better understanding of post COVID as a unique condition, sharing features with other post-viral syndromes, is needed. The healthcare burden and socio-economic consequences for children and their families warrant further investigation and development of appropriate healthcare management plans. The foremost requirement is the establishment of consistent and shareable definitions, as well as a consensus on outcomes, to effectively evaluate follow-up and quantify the burden of different viral infections. EU Horizon, 10.13039/501100001713 EDCTP , NIH.

2 August 2021 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
CMChiara Minotti
Chiara Minotti
MSManuela Scioni
Manuela Scioni
BCBiagio Castaldi
Biagio Castaldi
AGAlvise Guariento
Alvise Guariento
RBRoberta Biffanti
Roberta Biffanti
MPMassimo A. Padalino
Massimo A. Padalino
To evaluate early and long-term results of surgical treatment of aortic coarctation (CoAo) in neonates. This is a retrospective clinical review of neonates with CoAo, who underwent surgery between 1995 and 2019. Data were retrieved from our institutional database, to identify preoperative and postoperative characteristics. Statistical analysis was performed by means of relative risk ratio and Cox and logistic multivariate analysis. 218 consecutive neonates (M/F: 129/89, median age 11 days, IQR 7–17 days) were included; 202 (92.7%) had a left thoracotomy; 178 underwent extended end-to-end anastomosis (EEEA, 81.6%). Hypoplastic aortic arch (HAA) was present in 102 patients (46.8%); complex cardiac anomalies in 85 (39%). Significant postoperative complications occurred in 20 (9.2%). Thirty-day mortality was 2.3% (most in complex types). At a median follow-up of 10.4 years (IQR 5.6–15.0 years; FU completeness 95.9%), there were 8 late deaths (3.7%), all associated to complex CoAo. Among 196 survivors, 177 (93.2%) were in NYHA class I; re-interventions on aortic arch occurred in 9.2% (2.0% were surgical). Freedom from mortality and re-intervention on aorta at 10 years were 94.3% and 96.7%, respectively. Surgical repair of CoAo in newborns without CPB in our series was safe and low-risk, with excellent early and late outcomes.

11 May 2020 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SCSabrina Congedi
Sabrina Congedi
CMChiara Minotti
Chiara Minotti
CGCarlo Giaquinto
Carlo Giaquinto
LDLiviana Da Dalt
Liviana Da Dalt
DDDaniele Donà
Daniele Donà